Bioequivalence Study of Rivaroxaban

Clinical trial NCT02537457 · COMPLETED

Trial details

NCT number: NCT02537457
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Embolism, Atrial Fibrillation and Venous Thrombosis

Start date: 2014-01-01
Primary completion: 2014-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.